title: ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation.
abstract: The gene encoding a DNA/RNA binding protein FUS/TLS is frequently mutated in amyotrophic lateral sclerosis (ALS). Mutations commonly affect its carboxy-terminal nuclear localization signal, resulting in varying deficiencies of FUS nuclear localization and abnormal cytoplasmic accumulation. Increasing evidence suggests deficiencies in FUS nuclear function may contribute to neuron degeneration. Here we report a novel FUS autoregulatory mechanism and its deficiency in ALS-associated mutants. Using FUS CLIP-seq, we identified significant FUS binding to a highly conserved region of exon 7 and the flanking introns of its own pre-mRNAs. We demonstrated that FUS is a repressor of exon 7 splicing and that the exon 7-skipped splice variant is subject to nonsense-mediated decay (NMD). Overexpression of FUS led to the repression of exon 7 splicing and a reduction of endogenous FUS protein. Conversely, the repression of exon 7 was reduced by knockdown of FUS protein, and moreover, it was rescued by expression of EGFP-FUS. This dynamic regulation of alternative splicing describes a novel mechanism of FUS autoregulation. Given that ALS-associated FUS mutants are deficient in nuclear localization, we examined whether cells expressing these mutants would be deficient in repressing exon 7 splicing. We showed that FUS harbouring R521G, R522G or ΔExon15 mutation (minor, moderate or severe cytoplasmic localization, respectively) directly correlated with respectively increasing deficiencies in both exon 7 repression and autoregulation of its own protein levels. These data suggest that compromised FUS autoregulation can directly exacerbate the pathogenic accumulation of cytoplasmic FUS protein in ALS. We showed that exon 7 skipping can be induced by antisense oligonucleotides targeting its flanking splice sites, indicating the potential to alleviate abnormal cytoplasmic FUS accumulation in ALS. Taken together, FUS autoregulation by alternative splicing provides insight into a molecular mechanism by which FUS-regulated pre-mRNA processing can impact a significant number of targets important to neurodegeneration.
authors.affiliation: Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Manitoba, Canada ; Department of Biochemistry & Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada ; Regenerative Medicine Program, University of Manitoba, Winnipeg, Manitoba, Canada.
authors.forename: Yueqin
authors.initials: Y
authors.lastname: Zhou
authors.forename: Songyan
authors.initials: S
authors.lastname: Liu
authors.forename: Guodong
authors.initials: G
authors.lastname: Liu
authors.forename: Arzu
authors.initials: A
authors.lastname: Oztürk
authors.forename: Geoffrey G
authors.initials: GG
authors.lastname: Hicks
mesh_terms: D017398:Alternative Splicing / Q000235:genetics*; D000690:Amyotrophic Lateral Sclerosis / Q000209:etiology / Q000235:genetics* / Q000473:pathology; D003593:Cytoplasm / Q000235:genetics; D005091:Exons / Q000235:genetics; D005786:Gene Expression Regulation / Q000235:genetics*; D049452:Green Fluorescent Proteins / Q000235:genetics; D057809:HEK293 Cells; D006367:HeLa Cells; D006801:Humans; D007438:Introns / Q000235:genetics; D009154:Mutation; D012322:RNA Precursors / Q000096:biosynthesis / Q000235:genetics; D034702:RNA-Binding Protein FUS / Q000096:biosynthesis / Q000235:genetics
chemical_list: D012322:RNA Precursors; D034702:RNA-Binding Protein FUS; C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins